Advertisement

Topics

Goldfinch Bio Company Profile

15:44 EDT 25th June 2019 | BioPortfolio

Goldfinch Bio is a biotechnology company that is singularly focused on discovering and developing precision therapies for patients with kidney diseases. Just as the goldfinch has long been a symbol of healing and renewal and was a prominent figure of the Renaissance, Goldfinch Bio is leading a new age of therapeutic discovery to transform the treatment paradigm for patients with kidney diseases. Goldfinch was launched in 2016 by Third Rock Ventures, and is headquartered in Cambridge, Mass. For more information, please visit www.goldfinchbio.com.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Goldfinch Bio

Goldfinch Bio is a biotechnology company that is singularly focused on discovering and developing precision therapies for patients with kidney diseases. Just as the goldfinch has ...

More Information about "Goldfinch Bio" on BioPortfolio

We have published hundreds of Goldfinch Bio news stories on BioPortfolio along with dozens of Goldfinch Bio Clinical Trials and PubMed Articles about Goldfinch Bio for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Goldfinch Bio Companies in our database. You can also find out about relevant Goldfinch Bio Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record